PsyMed Ventures — Full Portfolio

CRISPR for live biotherapeutics and bacterial products

Ancilia is a biotech company using CRISPR to create beneficial bacterial products, such as live biotherapeutics, that carry immunity against the viruses that destroy them.

BiotechDeep TechHealthtechNew York, US

Rodolphe Barrangou(Co-founder)inAlex(Co-founder)inDavi Paez-Espino(Co-founder)Alexandra Sakatos(Executive Officer, Director)in

BoardDale Pfost(Director)VERA SCHROEDER(Director)

Co-investorsDeep Science VenturesMetaplanetSafar PartnersSnatched VenturesSpacecadet Ventures

Co-investorsLIONHEART VENTURESNoetic

Bloom Science is a clinical-stage biotech company developing live biotherapeutic products that replicate the effects of the ketogenic diet through the gut-brain axis.

BiotechDeep TechDigital HealthSan Diego, US

Co-investorsJoyance PartnersSocial Starts

Bright Minds Biosciences develops selective serotonin receptor agonists (5-HT2A and 5-HT2C) without 5-HT2B activity, built on a proprietary chemistry platform.

BiotechDeep TechHealthtechNew York, US

Alan Kozikowski(Executive Officer, Director)Ian McDonaldRyan Cheung(Chief Financial Officer)JAN PEDERSEN(Chief Science Officer)Gideon Shapiro(Executive Officer)Revati Sheeniwas(Executive Officer)

Delix Therapeutics develops third-generation, non-hallucinogenic neuroplastogens for people with neurological conditions, using a discovery platform to identify novel compounds.

BiotechDigital HealthMedical Devices

Co-investorsArtis VenturesCasa Verde CapitalNoeticOMX VenturesRA CapitalVertical Venture Partners+3 more

Freedom Biosciences develops neuropsychiatric therapeutics, focusing on novel treatments for conditions including depression, PTSD, and alcoholism.

BiotechDigital HealthMental Health

Dr. John Krystal(Co-founder & CEO)inDina Burkitbayeva(Co-founder)in

Co-investorsBeni Venture CapitalIter InvestmentsLongeVCManta Ray VenturesUnruly CapitalMBX Capital

Gilgamesh Pharmaceutical develops novel chemical entities for psychiatric disorders using medicinal chemistry and AI-powered translational platforms to design rapid-acting therapies targeting neurobiological mechanisms rather than symptom management.

AI & Machine LearningBiotechDigital HealthHealthtechNew York City, US

Jonathan Sporn(Founder)inAndrew Kruegel(Founder)inDalibor Sames(Founder)inJONATHAN SPORN(Founder)inAndrew Kruegel, Ph.D.(Executive Officer)Jonathan Sporn, M.D.(President and Chief Executive Officer)

Co-investorsAera VCFrontera Technology VenturesFrontier Path VCJames Beshara FundJLSMagnetic Ventures+4 more

Co-investorsSpacecadet VenturesAUTHENTIC VENTURES

ImYoo is a Public Benefit Corporation that provides at-home immune sample collection kits and molecular profiling to map patients' experiences to their underlying biology.

BiotechDigital HealthHealthtech

Co-investorsFREEFLOW

Iris Medicine is an early-stage biotech developing RNA therapies based on its small binding RNA (sbRNA) platform, which uses cooperative RNAi binding to selectively silence mutant genes carrying expanded pathologic repeat sequences while preserving healthy alleles.

BiotechDeep TechHealthtech

Megan Matthews(Co-founder & President)

Co-investorsVenrockUCB Ventures

Jimini Health offers Sage, an AI behavioral health assistant that works alongside clinicians to support patients before, after, and between therapy sessions, providing reminders, skill practice, and check-ins.

AI & Machine LearningDigital HealthMental Health

Bill Hudenko(Chief Clinical Officer)

Co-investorsCity LightLionBirdSCB 10X

Journey Clinical provides ketamine-assisted psychotherapy (KAP) for depression, anxiety, and PTSD, partnering patients with licensed therapists and medical teams while coordinating with major insurance providers.

Digital HealthMedical DevicesMental Health

Jonathan Sabbagh(Founder)in

Co-investorsAble PartnersAlleyCorpCoalition OperatorsFifty YearsMantis CapitalPROOF+2 more

Maya Health (Naitur) builds compliance-focused AI automation for independent health and wellness practices, covering intake-to-EMR sync, follow-ups, lab result delivery, rating-scale scoring, and safety escalation.

AI & Machine LearningDigital HealthHealthtech

Co-investorsInnovating CapitalLeafy Tunnel

Software platform helping psychedelic practitioners manage and measure health outcomes.

Co-investorsInnovating Capital

Mindstate Design Labs is a clinical-stage drug development company that uses AI to map the biological basis of emotion and cognition, synthesizing psychedelic phenomenology and biochemical data to design pharmaceutical compounds that induce specific therapeutic emotional and cognitive states for mental health treatment.

AI & Machine LearningBiotechHealthtechMental HealthSan Francisco, US

Dillan DiNardo(Founder/CEO)inTom Ray(Founder)in

BoardRand Hindi(Director)in

Co-investorsImmeasurableMetaplanetY Combinator

Motif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression.

BiotechDeep TechDigital HealthHealthtechMedical DevicesHouston, US

Sameer Sheth(Founder)inSunil Sheth(Founder)Nick Halper(Chief Operating Officer)inSteve Goetz(Chief Technology Officer)inAnthony Arnold(Director)

BoardJacob Robinson(Co-founder & CEO)in

Co-investorsArboretum VenturesTMC Venture FundCapital FactoryDivergent CapitalDolby Family VenturesKdT Ventures+2 more

Neurode develops a wearable neurostimulation headband paired with a companion app that provides personalized insights and recommendations from psychologists, neuroscientists, and engineers.

Digital HealthHardwareMental Health

Co-investorsStoic VC

Remepy develops "Hybrid Drugs" that combine pharmaceuticals with targeted digital interventions to deliver personalized and adaptive therapies for patients.

AI & Machine LearningBiotechDigital Health

Or Shoval(Founder)in

Co-investors97212 Venturesfresh.fundIT-Farm CorporationNFXO.G. Venture PartnersSamsung Next+2 more

Reset Pharma is a CNS-focused pharmaceutical company developing psilocybin and related psychedelics for the treatment of mental illness in patients with life-threatening diseases.

BiotechDigital HealthHealthtechMental HealthNew York, US

John Andreadis(Executive Officer, Director)Jan-Anders Karlsson(Executive Officer, Director)Philip Taub(Director)Tim Schlidt(Director)

Co-investorsIter Investments

Transcranial focused ultrasound for mental health

Programmable RNA splicing medicine for complex brain diseases

Precision biologics for neuroinflammation

Integrated solution for cancer-specific behavioral health

Marketplace for transformational mental health modalities

Tactogen develops patented new chemical entities, including benzofuran-based compositions, and conducts preclinical research and publishes data on these compounds.

BiotechDeep TechHealthtech

Matthew Baggott(CEO)

Co-investorsLeafy TunnelNoetic

Terran Biosciences is a biotech platform company developing therapeutics and technologies for neurological and psychiatric diseases, including late-stage drug candidates for schizophrenia, psychedelic and empathogen compounds, and an AI-based neuromelanin MRI analysis platform.

AI & Machine LearningBiotechDigital Health

Sam Clark(Chief Executive Officer)Dustin Tetzl(Chief Business Officer)

Co-investorsNoeticRed Beard Ventures

TRIPP provides immersive meditation and mindfulness experiences available through a mobile app and VR headset platform.

AgTechMental HealthWellness & FitnessVenice, US

Nanea Reeves(Executive Officer, Director)inZachary Norman(Executive Officer, Director)Kevin Keeland(Executive Officer)

BoardTim Chang(Director)

Co-investorsBeni Venture CapitalBitkraft Esports VenturesGrit Capital PartnersHartmann CapitalIter InvestmentsMayfield Fund+3 more